The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence

被引:109
作者
Bartlett, N
Symons, JA
Tscharke, DC
Smith, GL
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Wright Fleming Inst, Dept Virol, London W2 1PG, England
[2] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
关键词
D O I
10.1099/0022-1317-83-8-1965
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The vaccinia virus (VV) N1L gene encodes a protein of 14 kDa that was identified previously in the concentrated supernatant of virus-infected cells. Here we show that the protein is present predominantly (> 90%) within cells rather than in the culture supernatant and it exists as a nonglycosylated, non-covalent homodimer. The N1L protein present in the culture supernatant was uncleaved at the N terminus and was released from cells more slowly than the VV A41L gene product, a secreted glycoprotein that has a conventional signal peptide. Bioinformatic analyses predict that the N 1 L protein is largely alpha-helical and show that it is conserved in many VV strains, in other orthopoxviruses and in members of other chordopoxvirus genera. However, database searches found no non-poxvirus proteins with significant amino acid similarity to N 1 L. A deletion mutant lacking the N I L gene replicated normally in cell culture, but was attenuated in intranasal and intradermal murine models compared to wild-type and revertant controls. The conservation of the N I L protein and the attenuated phenotype of the deletion mutant indicate an important role in the virus life-cycle.
引用
收藏
页码:1965 / 1976
页数:12
相关论文
共 39 条
[1]   Viral mechanisms of immune evasion [J].
Alcami, A ;
Koszinowski, UH .
TRENDS IN MICROBIOLOGY, 2000, 8 (09) :410-418
[2]  
ALCAMI A, 1995, J VIROL, V69, P4633
[3]   A SOLUBLE RECEPTOR FOR INTERLEUKIN-1-BETA ENCODED BY VACCINIA VIRUS - A NOVEL MECHANISM OF VIRUS MODULATION OF THE HOST RESPONSE TO INFECTION [J].
ALCAMI, A ;
SMITH, GL .
CELL, 1992, 71 (01) :153-167
[4]  
Alcamí A, 1998, J IMMUNOL, V160, P624
[5]   The complete genomic sequence of the modified vaccinia Ankara strain: Comparison with other orthopoxviruses [J].
Antoine, G ;
Scheiflinger, F ;
Dorner, F ;
Falkner, FG .
VIROLOGY, 1998, 244 (02) :365-396
[6]   A DOMINANT SELECTABLE MARKER FOR THE CONSTRUCTION OF RECOMBINANT POXVIRUSES [J].
BOYLE, DB ;
COUPAR, BEH .
GENE, 1988, 65 (01) :123-128
[7]   DECREASED VIRULENCE OF RECOMBINANT VACCINIA VIRUS EXPRESSION VECTORS IS ASSOCIATED WITH A THYMIDINE KINASE-NEGATIVE PHENOTYPE [J].
BULLER, RML ;
SMITH, GL ;
CREMER, K ;
NOTKINS, AL ;
MOSS, B .
NATURE, 1985, 317 (6040) :813-815
[8]   The complete DNA sequence of myxoma virus [J].
Cameron, C ;
Hota-Mitchell, S ;
Chen, L ;
Barrett, J ;
Cao, JX ;
Macaulay, C ;
Willer, D ;
Evans, D ;
McFadden, G .
VIROLOGY, 1999, 264 (02) :298-318
[9]   ATTENUATED DELETION MUTANT OF VACCINIA VIRUS IHD-W RECOVERED VIRULENCE BY REINSERTION OF A TERMINAL RESTRICTION FRAGMENT [J].
CHANG, PY ;
LAI, ACK ;
POGO, BGT .
MICROBIAL PATHOGENESIS, 1992, 13 (01) :49-59
[10]   TRANSIENT DOMINANT SELECTION OF RECOMBINANT VACCINIA VIRUSES [J].
FALKNER, FG ;
MOSS, B .
JOURNAL OF VIROLOGY, 1990, 64 (06) :3108-3111